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Although communications between mammalian oocytes and their surrounding granulosa cells mediated by the Kit–Kit ligand (KL, or
stem cell factor, SCF) system have been proven to be crucial for follicular development, Kit downstream signaling pathways in mammalian
oocytes are largely unknown. In this study, by using ovaries and isolated oocytes from postnatal mice and rats, we demonstrated for the first
time that components of the PI3 kinase pathway, the serine/threonine kinase Akt (PKB) which enhances cellular proliferation and survival,
and an Akt substrate FKHRL1 which is a transcription factor that leads to apoptosis and cell cycle arrest, are expressed in mammalian
oocytes. By using an in vitro oocytes culture system, we found that oocytes-derived Akt and FKHRL1 are regulated by SCF. Treatment of
cultured oocytes with SCF cannot only rapidly phosphorylate and activate Akt, but also simultaneously phosphorylate and may therefore
functionally suppress FKHRL1, through the action of PI3 kinase. Together with our in situ hybridization and immunohistochemistry data that
Akt and FKHRL1 are mostly expressed in oocytes in primordial and primary ovaries and reports that FKHRL1 gene-deficient mice exhibited
excessive activation from primordial to primary follicles as well as enlarged oocyte sizes, we suppose that in mammalian oocytes, actions of
granulosa cell derived SCF on primordial to primary follicle transition and subsequent follicle development may involve activation of Akt
and inhibition of FKHRL1 activities in oocytes. The role of oocyte’s Akt may be to enhance follicle development and the role of oocyte’s
FKHRL1 may be to inhibit follicle development. We propose that the cascade from granulosa cell SCF to oocyte Kit-PI3 kinase-Akt-
FKHRL1 may play an important role to regulate the growth rate of mammalian oocytes and hypothetically also the oocyte secretion of factors
that may regulate the activation and early development of ovarian follicles.
D 2005 Elsevier Inc. All rights reserved.Keywords: Mammalian oocytes; Stem cell factor (SCF); Kit; PI3 kinase; Akt; FKHRL1Introduction
Themammalian ovary is a heterogeneous organ consisting
of follicles and corpora lutea at various developmental stages.
At the time of birth, the ovary is populated predominantly by
primordial follicles, each composed of a meiotically-arrested0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.02.013
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1 These authors contributed equally to this work.primordial oocyte enclosed within several flattered pregra-
nulosa cells. The development of follicles involves the
initial recruitment of primordial follicles from the resting
pool, the continued growth of the follicles, cyclic recruit-
ment of dominant follicles, ovulation and formation of
corpora lutea from the remnants of ovulated follicles (Elvin
and Matzuk, 1998; McGee and Hsueh, 2000; Ny et al.,
2002; Vanderhyden, 2002).
Each follicle contains an oocyte which is surrounded by
granulosa cells. The growth and meiotic regulation of81 (2005) 160 – 170
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1998; McGee and Hsueh, 2000; Vanderhyden, 2002;
Wassarman and Albertini, 1994). Previous studies have
suggested that oocytes are not quiescent cells that are solely
nursed by the surrounding granulosa cells, but rather they
play key roles in folliculogenesis. The bi-directional com-
munication between oocytes and somatic cells is essential
for the proliferation and differentiation of the granulosa cells
which maintains female reproduction (for reviews see
Albertini and Barrett, 2003; Eppig, 2001; Matzuk et al.,
2002; Nilsson and Skinner, 2001; Shimasaki et al., 2004;
Vanderhyden, 2002). The role of oocyte-derived factors
(such as GDF-9 and BMP-15) in follicular development
have been extensively studied by the usage of gene-deficient
mice (Dong et al., 1996; Elvin et al., 1999; Su et al., 2004;
Yan et al., 2001) and the mechanisms on how they influence
granulosa cells remain to be one of the most active research
areas in reproductive biology nowadays.
In the mouse, an initial synchronous wave of follicular
recruitment takes place within a few days of birth. By 10 to
12 days of postnatal life, a group of secondary-stage
follicles develops, in which oocytes are surrounded by
two or more layers of granulosa cells. Antral-stage follicles
form between 14 and 24 days when fluid-filled cavities
develop between the layers of somatic cells (Matzuk et al.,
2002). During follicular activation and early development,
oocytes and granulosa cells grow coordinately, but not
simultaneously, with definable morphological stages (Was-
sarman and Albertini, 1994). The mouse oocytes complete
growth from a diameter of about 12 Am to a final diameter
of about 80 Am (not including the zona pellucida) before
formation of a follicular antrum (Wassarman and Albertini,
1994). Although somatic cells grow from a single layer of a
few flattened pregranulosa cells to three layers of cuboidal
granulosa cells by the time the oocyte has completed its
growth, the vast majority of granulosa cell proliferation and
differentiation occurs after the oocyte has stopped growing
(Wassarman and Albertini, 1994).
Kit is a receptor protein tyrosine kinase (RPTK) that
leads to cellular proliferation, survival, adhesion, secretion
and differentiation upon activation by its ligand, stem cell
factor (SCF) or Kit ligand (KL) (Besmer et al., 1993; Kissel
et al., 2000). In postnatal ovaries of mouse, rat and human,
Kit is present in oocytes at all stages of follicular develop-
ment (Horie et al., 1991; Manova et al., 1990; Orr-Urtreger
et al., 1990, 1993). SCF is produced by the surrounding
granulosa cells (Ismail et al., 1996; Laitinen et al., 1995;
Manova et al., 1993; Motro and Bernstein, 1993). The
function of Kit/SCF in follicular development has been
investigated thoroughly for decades (for reviews see
Albertini and Barrett, 2003; Besmer et al., 1993; Eppig,
2001; Matzuk et al., 2002; Nilsson and Skinner, 2001;
Otsuka and Shimasaki, 2002; Vanderhyden, 2002). Several
lines of evidence suggested that Kit may play an essential
role in oocyte growth and follicular development (Huang et
al., 1993; Kuroda et al., 1988; Packer et al., 1994). Forexample, in vitro or in vivo administration of Kit blocking
antibodies in mice disturbed postnatal follicular growth,
indicating that ovarian follicle growth is dependent on Kit at
a time when functional FSH receptors are not yet expressed
in mouse ovary (Parrott and Skinner, 1999; Yoshida et al.,
1997). And mice carrying a mutated Kit molecule where the
PI3 kinase pathway signaling was blocked were reported to
be sub-fertile due to arrested follicle development at the
primary stages (Kissel et al., 2000).
However, little is known about the Kit downstream
signaling pathways inside the mammalian oocytes. To
address this question, we have used postnatal mouse and
rat ovaries for localization and signal transduction studies of
the PI3 kinase pathway components in oocytes. Our results
suggest that the oocyte PI3 kinase pathway is regulated by
SCF of the granulosa cells and is of great importance for
early follicular development.Materials and methods
Reagents, antibodies, and immunologic detection methods
Restriction enzymes, 4-nitro blue tetrazolium chloride, 5-
bromo-4-chloro-3-indolyl-phosphate, anti-digoxigenin-AP
Fab fragments and the Dig RNA labeling kit for synthesis
of riboprobes for in situ hybridization were from Roche
Molecular Biochemicals (Roche Diagnostics Scandinavia
AB, Bromma, Sweden). The Kit neutralizing antibody
ACK2 was purchased from eBiosciences (San Diego, CA).
The PI3 kinase inhibitor LY 294002, recombinant mouse
stem cell factor (rmSCF) and mouse monoclonal antibody
against Src were from EMD Biosciences (San Diego, CA,
USA). Rabbit polyclonal antibodies against Akt (PKB),
phosphorylated-Akt (Ser473), p44/42 mitogen-activated
protein kinase (MAPK, or ERK), phosphorylated-p44/42
MAPK (Thr202/Tyr204, p-MAPK) were from Cell
Signaling Technologies (Beverly, MA, USA). Rabbit
polyclonal antibody against phosphorylated-FKHRL1
(Thr32) and FKHRL1 were from Upstate Biotechnology
(New York, NY, USA). Mouse monoclonal antibody
against h-actin was purchased from Sigma-Aldrich (Sigma-
Aldrich Sweden AB, Stockholm, Sweden). Anti-mouse and
anti-rabbit secondary antibodies coupled to horseradish
peroxidase (HRP) were from BioRad (Hercules, CA,
USA). Western blot analyses were carried out according to
instructions for antibodies from the manufacturers and
developed using the ECL Plus Western Blotting Detection
System (Amersham Biosciences, Uppsala, Sweden).
Animals
C57BL/6 mice and Sprague–Dawley rats were obtained
from Bomholtgaard Breeding and Research Center Ltd-
Boommice (Ry, Denmark). The animals were housed under
controlled environmental conditions with free access to
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18:00 h. Experimental protocols were approved by the
regional ethical committee of Umea˚ University.
Preparation of ovarian extract
Ovaries were dissected free of fat and adhering tissues and
kept at80-C for further analyses. Ovaries of postnatal mice
of 8, 12, and 15-day-old (N = 8–10) were transferred to a
pre-cooled homogenizer and extracts were prepared on ice in
a lysis buffer containing 50 mM Tris–HCl (pH 8.0), 120 mM
NaCl, 20 mM NaF, 20 mM h-glycerophosphate, 1 mM
EDTA, 6 mM EGTA (pH 8.0), 1% NP-40, 1 mMDTT, 5 mM
benzamidine, 1 mM PMSF, 250 AM sodium vandadate, 2 Ag/
ml aprotinin, 10 Ag/ml leupeptin and 1 Ag/ml pepstatin
followed by centrifuging at 14,000 rpm for 20 min at 4-C.
The supernatants were collected and protein concentrations
were measured using the bicinchoninic acid (BCA) protein
assay.
Synthesis of RNA probes
A fragment of mouse FKHRL1 cDNA (nucleotides
329–867) and full length mouse Akt cDNA were sub-
cloned into pGEM 3Z vector. The mouse FKHRL1 cDNA
was a generous gift from Dr Motoyamo N., National Institute
for Longevity Sciences, Japan. The mouse Akt cDNAwas a
generous gift from Dr. Franke T. from Columbia University,
USA. Before transcription, plasmids were linearized such
that antisense or sense RNA probes could be obtained. The
riboprobes used for in situ hybridization were labeled with
digoxigenin labeled UTP using the Dig RNA labeling kit
(Roche Diagnostics Scandinavia AB, Bromma, Sweden).
In situ hybridization
Mice were sacrificed by decapitation, and the ovaries
were collected and frozen in Tissue-Tec OCT compound
(Miles, Elkhart, IL) before being stored at 80-C for further
use. In situ hybridization was performed on 10 Am cryostat
sections using digoxigenin-labeled antisense riboprobes as
previously described (Liu et al., 1996; Schaeren-Wiemers
and Gerfin-Moser, 1993). Sense strands of the probes were
used in parallel as background controls.
Immunohistochemistry analyses
Cryostat sections of 10 Am of mouse ovaries were
collected on Super-Frost slides, air dried and fixed in 4%
paraformaldehyde at room temperature for 15–20 min.
Immunostaining was then performed with an anti-FKHRL1
antibody (Upstate Biotechnology) at a concentration of
24 Ag/ml. The bound primary antibody was detected with
an Avidin–Biotin Complex (ABC) staining kit from Santa
Cruz Biotechnology (Santa Cruz, CA, USA) according to
the instructions of the manufacturer. Slides incubatedwithout primary antibody were used as negative controls.
The sections were counter-stained with hematoxylin.
Isolation of growing oocytes from postnatal mouse or rat
ovaries
To obtain mouse oocytes at their active growing stage,
we have used postnatal day 8 female C57BL/6 mouse
ovaries based on previous literature (Matzuk et al., 2002;
Wassarman and Albertini, 1994) and our own morpholog-
ical observation that primordial follicles are the predominant
population of follicles while some primary follicles also
exist, and no follicular antrum was observed (data not
shown). The mice were sacrificed by decapitation, and
ovaries were dissected free of fat and connective tissues
under the microscope. The ovaries were then minced with a
pair of dissection scissors before being incubated in 0.05%
collagenase dissolved in Dulbecco’s modified Eagle’s
medium-F12 (DMEM/F12, Life Technologies, Inc.) supple-
mented with 4 mg/ml bovine serum albumin (BSA) and 100
units/ml penicillin and 100 Ag/ml streptomycin, with
frequent agitation and pippetting. After the tissues were
digested by collagenase during a period of 45–60 min,
EDTA was added to the mixture to a final concentration of
40 mM, and the mixture was incubated at 37-C with
frequent pippetting for another 15–20 min until clusters of
granulosa cells were dispersed into individual cells. The
mixture of granulosa cells, blood cells and oocytes was then
cultured in a 10 cm tissue culture dish with the above
mentioned serum-free DMEM/F12 media for 6–8 h to
allow the granulosa cells to attach to the plastic culture
bottom. The unattached oocytes were then recovered by
collecting the supernatant and centrifugation (1000 rpm,
5 min at room temperature). Oocytes obtained by this
method are basically free of granulosa cell contaminations.
The sizes of oocytes we obtained as measured by our
microscope are at the range of 15–41 Am, representing a
population of growing oocytes. Equal volumes of oocytes
were aliquoted into wells of a 24-well plate (approximately
500 oocytes/per each well) and maintained at 37-C in a
humidified atmosphere of 5% CO2 and 95% air in 1 ml of the
DMEM/F-12 media for stimulation with SCF.
To obtain rat oocytes during their growing periods, we
have used 5-day-old female rats based on the observation
that ovaries at this stage contain mainly primary and
primordial follicles. A similar approach as mentioned above
was undertaken to isolate the growing rat oocytes. The sizes
of the rat oocytes we obtained are between 13–38 Am as
measured by our microscope, representing a population of
growing rat oocytes.
Isolation of partially grown oocytes from postnatal mouse
or rat ovaries
To obtain partially grown oocytes (oocytes from pre-
antral follicles), we have used 15-day-old mice and rats
Fig. 1. Expression of Akt and FKHRL1 proteins in postnatal mouse ovaries.
Ovaries from postnatal female mice of 8, 12, and 15 days were collected and
homogenized as described in Materials and methods. Eighty micrograms of
each sample was separated on SDS–PAGE and analyzed by Western blot.
(A) Levels of phosphorylated Akt (Ser 473) and total Akt; (B) levels of
phosphorylated FKHRL1 (Thr 32) and total FHKRL1; (C) levels of h-actin
in the lysates. D8, D12 and D15 correspond to days of postnatal ages of the
mice. Experiments were repeated at least 3 times and representative results
were shown. N = 8–10 for each time point in each experiment.
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pre-antral follicles containing 2–3 layers of granulosa cells,
indicating that the oocytes have passed their most active
growing period (Matzuk et al., 2002; Wassarman and
Albertini, 1994). A similar but slightly different method
was used to obtain the partially grown oocyte from mice
and rats. After the ovaries were digested with 0.05%
collagenase and granulosa cells clusters were disrupted by
EDTA (40 mM), instead of culturing the mixture of oocytes
and granulosa cells in a CO2 incubator, we have let the
mixture go through a cell dispersing screen with 25.4 Am
opening to dispose of the majority of granulosa cells and
other unwanted tissue debris. The screen holding oocytes
was then gently rinsed twice with 20 ml culture media. To
recover the oocytes, the screen was turned over with a pair
of forceps and the side holding the oocytes was immersed
into 8–10 ml culture media in a 6 cm culture dish and kept
in the media for 10 min with frequent gentle agitation to
allow the detachment of oocytes into the media. Centrifu-
gation was avoided as oocytes at this stage were found to be
hard to enrich at a speed of 1000 rpm for 5 min, and higher
centrifugation speed or longer spinning time usually caused
breakage of the oocytes. Oocytes obtained by this method
are basically free of granulosa cell contaminations. The
sizes of 15-day-old mouse oocytes isolated by this method
are at a range of 33–61 Am as observed microscopically,
which was in agreement with reported size of oocytes at this
developmental stage (Wassarman and Albertini, 1994).
Equal volumes of oocytes were then aliquoted into wells
of a 24-well plate (approximately 350 oocytes/per well) and
maintained at 37-C in a humidified atmosphere of 5% CO2
and 95% air in 1 ml of the DMEM/F-12 media for 4–6 h of
starvation in serum-free media. Oocytes from 15-day-old
rats were isolated with a similar approach and the sizes of
oocytes fell in a range of 50–65 Am as measured by our
microscope.
Stimulation of isolated oocytes with SCF
The expression of Kit receptor in granulosa cell-free
oocytes cultured in starvation media was maintained for up
to 48 h (the longest time studied) (data not shown). After
starvation in serum-free media, oocytes in the 24-well plates
were treated for 2, 5, 7.5, 15, 30 and 60 min with 150 ng/ml
SCF. The concentration and stimulation time of SCF we
adopted are commonly used conditions in other cell types
for activating the Kit receptor tyrosine kinase in vitro
(Kissel et al., 2000; Voytyuk et al., 2003). For combined
treatment of SCF and the PI3 kinase inhibitor LY 294002,
the oocytes were pre-treated for 1 h with LY 294002 at a
concentration of 25 AM (which concentration and duration
were well-established to suppress the PI3 kinase activity in
many other cell types) (Vlahos et al., 1994) and followed by
SCF stimulation.
After SCF stimulation, the 24-well plate was chilled on
ice, and oocytes were collected into Eppendorf tubes,washed once with cold PBS and lysed in the lysis buffer
used for preparing ovarian lysates (see Preparation of
ovarian extract) on ice for 20 min with frequent votexing.
The lysates were collected by centrifuging at 14,000 rpm for
20 min at 4-C and used for further analyses by Western blot.
Statistical analysis
All experiments were repeated at least 3 times, and
representative data were shown. For experiments of Western
blot analyses with cultured oocytes, typically 25–30
animals were used each time, and their oocytes were pooled
and aliquoted into the wells. Approximately 500 oocytes/
lane for oocytes from primordial/primary follicles and 350
oocytes/lane for oocytes from pre-antral follicles were used.Results
Expression of Akt and FKHRL1 in postnatal mouse ovaries
Of interests, we have first of all measured protein levels
of the major PI3 kinase pathway components, the serine/
threonine kinase, Akt, as well as its substrate FKHRL1, in
mouse postnatal ovaries. We have used mouse postnatal
ovaries at days 8 (representing primordial and primary
follicles), 12 and 15 (representing pre-antral follicles) for
preparation of ovarian extracts. Expression of total Akt, total
FKHRL1, phosphorylated Akt (indicating functionally
activated Akt) and phosphorylated FKHRL1 (indicating
functionally suppressed FKHRL1) were measured by West-
ern blot in the ovarian extracts. As shown in Fig. 1, both Akt
(Fig. 1A, total Akt) and FKHRL1 (Fig. 1B, total FKHRL1)
were found to be expressed in the postnatal mouse ovaries
during the developmental period from primordial to pre-
antral follicles. Expression of phosphorylated Akt (Fig. 1A,
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were also seen in the ovarian extracts, indicating the
existence of activated Akt and functionally suppressed
FKHRL1 in the postnatal mouse ovaries.
To study the localization of FKHRL1 and its upstream
kinase Akt in postnatal mouse ovaries, we have performed
in situ hybridization and immunohistochemical analyses
using mouse postnatal ovaries at day 4 (mostly primordial
follicles), day 8 (primordial and primary follicles) and day
15 (secondary follicles and further developed follicles). As
shown in Fig. 2, FKHRL1 mRNA expression in postnatal
day 4 (Fig. 2A, arrow) and day 8 (Figs. 2B and C, arrows)
mouse ovaries was mainly detected in oocytes. Akt mRNA
was found to be expressed mainly in primordial and primary
oocytes (Fig. 2E, arrow), with lower expressions in the
surrounding granulosa cells (Fig. 2E, arrowhead). When
follicles grow beyond the primary stage and obtain more
than 2 layers of granulosa cells, the mRNA expression of
FKHRL1 and Akt was not only seen in oocytes of
developing follicles (Figs. 2D and F, arrows), but also in
surrounding granulosa cells in high levels (Figs. 2D and F,
arrowheads). The expression of FKHRL1 mRNA in oocytes
of secondary follicles (Fig. 2D, small arrow) seems to be
lower than that in the primary follicles (Fig. 2D, arrow).
To confirm the data obtained at the mRNA level, we have
also performed immunohistochemical analyses for FKHRL1
in mouse ovaries at different ages after birth. As shown in
Fig. 3, FKHRL1 was expressed in oocytes of primordial
(Fig. 3A, arrow) and primary (Fig. 3B, arrow) follicles. In
pre-antral follicles as shown in Fig. 3C, FKHRL1 was
detected in oocytes (Fig. 3C, arrow) as well as in surrounding
granulosa cells (Fig. 3C, arrowhead). The expression ofFig. 2. Localization of FKHRL1 and Akt mRNA in postnatal mouse ovaries by
Materials and methods. The hybridization signals appear as blue/dark blue color. FK
E) and 15-day-old (D and F) mice were shown. The horizontal black bars represen
results were shown.FKHRL1 in oocytes was mostly seen in the nuclei (Figs.
3A–C, arrows). The background level of immunohisto-
chemistry was shown in Fig. 3D.
SCF regulation of activation states of Akt and FKHRL1 in
oocytes isolated from primordial and primary follicles of
mice and rats
To study if factors from the granulosa cells can regulate
the activation states of Akt and FKHRL1 in oocytes, we
have examined how SCF, one of the major growth factors
originated from granulosa cells, may regulate oocyte Akt
and FKHRL1 phosphorylation via the oocyte surface SCF
receptor Kit. For obtaining a relatively complete under-
standing on PI3 kinase pathway signaling in mammalian
oocytes, we have used both mouse (8-day-old) and rat (5-
day-old) oocytes. To calm down active kinase levels inside
the oocytes, we have first starved the isolated oocytes in
serum-free DMEM/F-12 media. The oocytes were then
stimulated for various periods of time ranging from 2 to
60 min with a recombinant mouse SCF. To study the role
of PI3 kinase in the signaling pathways of oocytes, we
have also pre-treated the starved oocytes with a specific
PI3 kinase inhibitor LY 294002 for 1 h before the SCF
stimulation.
As validated in Fig. 4-1, treatment with SCF of isolated
8-day-old mouse oocytes for 2 min can elevate the level of
phosphorylated Akt (Serine 473). However, the SCF
induction of p-Akt can be completely blocked by pre-
treatment with a Kit neutralizing antibody ACK2, indicating
that the activation of Akt was achieved indeed via the SCF-
Kit receptor binding.in situ hybridization. In situ hybridization was performed as described in
HRL1 and Akt mRNA expression in postnatal ovaries of 4 (A), 8 (B, C and
t 25–125 Am. Experiments were repeated at least 3 times and representative
Fig. 3. Localization of FKHRL1 antigen in postnatal mouse ovaries by immunohistochemistry. Immunohistochemistry was performed as described in
Materials and methods. Mouse postnatal ovaries were sectioned and stained for FKHRL1 and counter-stained with hematoxylin. The immunohistochemistry
signals appear as brown color and counter-staining background appears as blue color. Expressions of FKHRL1 antigen in mouse ovaries from postnatal day
4 (A), 8 (B) and 15 (C) as well as the negative control (D) were shown. The horizontal black scale bars represent 25–50 Am. Experiments were repeated at
least 3 times and representative results were shown.
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8-day-old mice with SCF rapidly (2 min after stimulation)
induced the phosphorylation of Akt (Fig. 4-2A, p-Akt,
Lane 2). However, the phosphorylation of Akt was only
temporary which calmed down during a period of 5–60
min (Fig. 4-2A, p-Akt, Lanes 3–7). The pre-treatment of
oocytes with a specific PI3 kinase inhibitor LY 294002
completely abolished the phosphorylation of Akt (Fig. 4-
2A, p-Akt, Lane 8), indicating that Akt is activated solely
through PI3 kinase. As internal controls, total levels of Akt
at different time points were found to be basically equal
(Fig. 4-2A, Total Akt, Lanes 1–8), indicating that the
stimulation and inhibition of phosphorylated Akt levels
were not caused by uneven loading of oocyte lysates.
In addition, we have also studied whether and through
what pathway the oocyte FKHRL1 is manipulated by the
granulosa cell-derived SCF. As shown in Fig. 4-2B, in a
similar experimental setup as Fig. 4-2A, the activation state
of oocyte FKHRL1 was also controlled by SCF. FKHRL1
is known to be phosphorylated by Akt thereby be func-
tionally suppressed (Accili and Arden, 2004). We showed
that FKHRL1 can be rapidly phosphorylated by SCF in
vitro, at 2 min after addition of SCF to the culture media
(Fig. 4-2B, p-FKHRL1, Lane 2). However, different from
Akt, SCF induced a sustained phosphorylation of FKHRL1,
from 2 to 60 min of SCF treatment (Fig. 4-2B, p-FKHRL1,
Lanes 2–7). The SCF-induced phosphorylation of FKH-
RL1 can also be completely suppressed by the PI3 kinase
inhibitor LY 294002 (Fig. 4-2B, p-FKHRL1, Lane 8),
indicating the dependence of FKHRL1 phosphorylation onPI3 kinase. The total levels of FKHRL1 (Fig. 4-2B, Total
FKHRL1) as well as h-actin (Fig. 4-2E) were also shown as
internal controls for equal loadings.
A similar increment in phosphorylation of Akt and
FKHRL1 by SCF was also observed in oocytes of pri-
mordial and primary follicles in rats (Figs. 4-2F and G),
which were also inhibited by the PI3 kinase inhibitor LY
294002 to a large extent. Internal loading control (total
MAPK levels) of the samples was shown in Fig. 4-2H.
However, in rat oocytes, SCF stimulated p-Akt was
sustained for up to 60 min (Fig. 4-2F), which is significantly
different as compared to the transient stimulation of p-Akt
by SCF in mouse oocytes (Fig. 4-2A).
Of interest, we have also examined the activation of
MAPK and Src pathways by SCF in primordial and primary
oocytes of mouse and rat. As indicated by the levels of
phosphorylated MAPK (Fig. 4-2C, p-MAPK) and phos-
phorylated Src (Fig. 4-2D, p-Src), neither MAPK nor Src was
found to be further activated by SCF in oocytes of primordial
and primary follicles in the mouse or rat (not shown).
SCF regulation of activation states of Akt and FKHRL1 in
partially grown oocytes of mice and rats
We next studied how the PI3 kinase pathway in mouse
and rat oocytes from pre-antral follicles may be regulated by
granulosa cell-derived SCF. The isolated oocytes were
starved and stimulated similarly with 150 ng/ml recombinant
mouse SCF for various length of times ranging from 2 min to
60 min. As shown in Fig. 4-3, similar to primordial and
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Fig. 4. SCF regulated phosphorylation of Akt, FKHRL1, MAPK, MEK and Src in mouse and rat oocytes. Oocytes were isolated from 8 or 15-day-old mice, or
5 or 15-day-old rats, starved, and stimulated with 150 ng/ml SCF for 2, 5, 7.5, 15, 30 and 60 min, or pre-treated with the PI3 kinase inhibitor LY 294002 (LY)
for 1 h before the treatment with SCF for 2 min, as described in Materials and methods. (4-1) Validation of SCF-Kit mediated activation of signaling molecules.
Oocytes from 8-day-old mice were isolated, pre-treated with a Kit neutralizing antibody ACK2 (10 Ag/ml) for 12 h before stimulated with SCF for 2 min.
Levels of phosphorylated Akt (p-Akt) and h-actin were shown. (4-2) SCF regulated phosphorylation of Akt, FKHRL1, MAPK and Src in oocytes isolated from
8-day-old mice and 5-day-old rats. Upper panel: results from mice. (A) Levels of phosphorylated Akt (Ser 473) and total Akt; (B) levels of phosphorylated
FKHRL1 (Thr 32) and total FKHRL1; (C) levels of phosphorylated MAPK 1/2 (Thr 202/Tyr 204); (D) levels of phosphorylated Src (Try 416); (E) levels of h-
actin. Lower panel: results from rats. (F) Levels of phosphorylated Akt (Ser 473); (G) levels of phosphorylated FKHRL1 (Thr 32); (H) levels of total MAPK as
loading controls. (4-3) SCF induced phosphorylation of FKHRL1, Akt, MAPK, MEK and Src in oocytes isolated from 15-day-old mice and rats. Upper panel:
results from mice. (A) Levels of phosphorylated FKHRL1 (Thr 32); (B) levels of phosphorylated Akt (Ser 473) and total Akt; (C) levels of phosphorylated
MAPK (Thr 202/Tyr 204) and total MAPK; (D) levels of phosphorylated MEK (Ser 217/221) and total MEK; (E) levels of phosphorylated Src (Tyr 416) and
total Src. Lower panel: results from rats. (F) levels of phosphorylated Akt (Ser 473) and total Akt; (G) levels of phosphorylated FKHRL1 (Thr 32) and total
FKHRL1. All experiments were repeated at least 3 times and representative results were shown. For each experiment, 25–30 animals were used. (4-4)
Summary of phosphorylated molecules as determined by densitometric analysis. For each molecule in oocytes of a certain age, the maximal stimulated level by
SCF was defined as 1.0, and from this value all other values from the same experiment were calculated. Note that the relative density of a molecule is only
comparable to time points of the same set of experiment. The relative densities are not comparable among different molecules, oocyte ages or species. Data
represent the relative mean values with standard deviations (N  3). (A) Phosphorylated Akt in mouse oocytes; (B) phosphorylated FKHRL1 in mouse
oocytes; (C) phosphorylated MAPK and phosphorylated MEK in mouse oocytes; (D) phosphorylated Src in mouse oocytes; (E) phosphorylated Akt in rat
oocytes; (F) phosphorylated FKHRL1 in rat oocytes.
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induced the phosphorylation of Akt in partially grown
oocytes of mouse (Fig. 4-3B, Lanes 2–7) and rat (Fig. 4-
3F, Lanes 2–7). The activation of Akt by SCF was sustained
from 2 min to 60 min after treatment (Figs. 4-3B and F,
Lanes 2–7). Also similar to oocytes from primordial andprimary follicles, treatment of partially grown oocytes with
SCF can rapidly induce the phosphorylation of FKHRL1
throughout the entire periods of SCF stimulation (2 to 60
min) in mouse (Fig. 4-3A, Lanes 2–7) and rat (Fig. 4-3G,
Lanes 2–7). The phosphorylation of Akt and FKHRL1 was
completely blocked by treatment with the PI3 kinase
P. Reddy et al. / Developmental Biology 281 (2005) 160–170168inhibitor LY 294002, indicating that the phosphorylation of
Akt and FKHRL1 were mediated by PI3 kinase.
MAPK and Src signaling pathways were activated by SCF
in mouse partially grown oocytes
As shown in Figs. 4-3C–E, different from primordial and
primary oocytes (Fig. 4-2), both MAPK and Src were
phosphorylated by SCF in mouse partially grown oocytes.
The SCF stimulation of phosphorylated MAPK (Fig. 4-3C)
was accompanied by the activation of its upstream kinase
MEK, as indicated by the elevated levels of phosphorylated
MEK (Fig. 4-3D). Both MEK and MAPK were phosphory-
lated at 5 min of SCF treatment (Figs. 4-3C and D, Lanes 3).
The temporary phosphorylation of MAPK and MEK
decreased at 15 min of SCF treatment (Figs. 4-3C and D,
Lanes 5). Src in the partially grown mouse oocytes was also
activated by the treatment of SCF, with the peak of
phosphorylated Src at 15–30 min after SCF treatment
(Fig. 4-3E, Lanes 5–6). However, the SCF activation of the
MAPK and Src pathways in oocytes from rat pre-antral
follicles was not obvious (data not shown).
To provide a more graphic and quantitative presentation
of the data and also to show the experimental reproduci-
bility, fluctuations of different kinases were also summa-
rized in a graph where relative levels of phosphorylated
kinases from primordial/primary and pre-antral follicles
were combined in Fig. 4-4.Discussion
The involvement of SCF and Kit in mammalian oogenesis
and follicular development has been studied thoroughly over
the last decade. The indispensable roles of SCF/Kit in the
above mentioned processes have been well-established by
both in vitro and in vivo approaches including the usage of
naturally occurred or induced Kit or SCF mutant mice
(Besmer et al., 1993; Eppig, 2001; Kissel et al., 2000;
Nilsson and Skinner, 2001; Vanderhyden, 2002). However,
the Kit downstream signaling pathways in mammalian
oocytes remain largely unknown. Our results from the
current study demonstrated for the first time that, via binding
to Kit receptor on oocytes surface, granulosa cell-derived
SCF can activate the PI3 kinase pathway of the oocytes. This
activation of PI3 kinase in the oocytes leads to the
phosphorylation of the serine/threonine kinase Akt and the
transcription factor FKHRL1 in mouse and rat oocytes,
which most likely results in the activation of Akt and
suppression of FKHRL1. We therefore suggest that the PI3
kinase pathway in the oocytes is regulated by the surround-
ing granulosa cells, and it is our speculation that the
activation of oocyte PI3 kinase pathway might be of
importance for the bi-directional dialogue between oocytes
and granulosa cells which is crucial for follicular activation
and development.Akt is a signaling molecule that is known to enhance cell
proliferation, survival as well as glycogen and protein
synthesis (Blume-Jensen and Hunter, 2001). FKHRL1 is a
substrate of Akt, and it is a transcription factor that leads to
apoptosis and cell cycle arrest. Upon phosphorylation,
FKHRL1 is excluded from the nuclei and is suppressed from
functioning as a transcription factor (Accili andArden, 2004).
As the activation of individual follicles involves unknown
triggering mechanisms intrinsic to the ovary before the action
of FSH comes to place (Elvin andMatzuk, 1998; Peters et al.,
1975), our data suggested that actions of SCF on primordial
to primary follicle transition and subsequent follicle develop-
ment may involve activation of Akt and inhibition of
FKHRL1 activities in oocytes. Actions of SCF are therefore
in part mediated by Akt and FKHRL1. We hypothesize that
the role of oocyte’s Akt may be to enhance follicle develop-
ment and the role of oocyte’s FKHRL1 may be to inhibit
follicle development. Our finding that SCF is able to regulate
the function of the ‘‘positive molecule’’ Akt and the ‘‘negative
molecule’’ FKHRL1 at the same time in oocytes suggests that
the SCF-Kit-PI3 kinase-Akt-FKHRL1 cascade integrated by
oocyte–granulosa cell communication might be important
ovarian intrinsic factors for follicular activation. As this
activation cascade was constantly seen in oocytes of
primordial and primary follicles as well as in oocytes of
pre-antral follicles, we suggest that the Kit downstream PI3
kinase pathway in oocytes is of great importance for oocyte
growth and hypothetically also for oocyte secretion of factors
that influence granulosa cell proliferation and differentiation.
One interesting finding of this study is the localization of
FKHRL1 in oocytes of postnatal mouse ovaries and the in
vitro phosphorylation of oocyte FKHRL1 by recombinant
SCF. Recently, FKHRL1-deficient mice were reported to
exhibit the phenotype of excessive activation from primor-
dial to primary follicles, enlarged primary oocyte sizes and
female infertility in adult life from 3 independent research
groups studying cancers or immunology (Castrillon et al.,
2003; Hosaka et al., 2004; Lin et al., 2004). As compared to
phenotypes of mice lacking other members of the Foxo
subclass of forkhead transcription factors (FKHR and AFX)
(Hosaka et al., 2004), only FKHRL1 seems to be the key
molecule in the family that plays a role in regulating ovarian
function. Nevertheless, how FKHRL1 is localized in
different ovarian cell types, how it is regulated inside the
ovary and how it may play its role to suppress follicular
activation and early development were not addressed by
these reports (Castrillon et al., 2003; Hosaka et al., 2004; Lin
et al., 2004). FKHRL1 has been reported to be expressed in
rat corpus luteum of adult life (Richards et al., 2002). Our
data from the current study demonstrated that, in mouse
primordial and primary follicles, FKHRL1 was mainly
expressed in oocytes. FKHRL1 protein was found to be
mostly expressed in the nuclei of mouse primordial and
primary oocytes. Based on current understandings of
FKHRL1, the nuclear localization implies an active state
of this pro-apoptosis and cell cycle arrest transcription
P. Reddy et al. / Developmental Biology 281 (2005) 160–170 169factor. Our results therefore indicate that FKHRL1 might be
the negative regulator for oocyte growth and probably also
functions. Thus, we propose that the excessive activation
from primordial to primary follicles observed by Castrillon
et al. (2003) was mostly caused by the absence of FKHRL1
in oocytes, which was not made clear by Brenkman and
Burgering in their review appraising Castrillon et al.’s work.
(Brenkman and Burgering, 2003). Our data reinforced the
theory that oocytes carry signals that are key for follicular
activation and development (Albertini and Barrett, 2003;
Eppig, 2001; Matzuk et al., 2002; Nilsson and Skinner,
2001; Shimasaki et al., 2004; Vanderhyden, 2002). In
addition, as our data showed that oocytes’ FKHRL1 can
be phosphorylated and therefore may be functionally sup-
pressed by SCF when compared to other systems (Accili and
Arden, 2004; Lin et al., 2004), we have also partly answered
the question that what hormones or growth factors regulate
the function of ovarian FKHRL1, which was raised also in
Brenkman and Burgering’s review (Brenkman and Burger-
ing, 2003). Based on our current data, we propose that
oocyte-derived Akt and FKHRL1, both under the control of
granulosa cell-derived SCF, may be a pair of balancing
molecules that manipulates not only the growth rates and
secretion conditions of oocytes, but also the activation and
early development of ovarian follicles.
Our hypothesis was supported by the report that
FKHRL1-deficient mice exhibited enlarged oocytes at
postnatal day 8 already (Castrillon et al., 2003). Moreover,
GDF-9 knock out mice that exhibited a 32-fold increment in
expression of SCF in granulosa cells also exhibited enlarged
oocyte size (Elvin et al., 1999), implying that the sub-
stantially elevated level of SCF may constantly activate the
PI3 kinase pathway in the oocytes by activating Akt and
suppressing FKHRL1, which enhanced the oocyte growth.
Taken together with data from the current study, we suggest
that the cascade from granulosa cell SCF to oocyte Akt-
FKHRL1 may control the growth rate of oocytes.
The activation of Kit downstream MAPK and Src
pathways by SCF in oocytes was also studied in this work.
We showed a development/species-dependent activation of
MAPK and Src by SCF in oocytes: MAPK and Src were
only activated in mouse oocytes isolated from pre-antral
follicles, but not in oocytes from primordial and primary
mouse follicles, or in any type of rat oocytes studied. From
previous studies, the roles of MAPK in oocytes have been
mostly studied on oocyte meiosis resumption in both
Xenopus and mice (Verlhac et al., 2000). However, as the
mouse oocytes at postnatal day 15 used in this study are
distant from meiosis resumption, we suggest that the SCF
activated MAPK and Src pathways in mouse oocytes may
play a role in enhancing the growth and probably also
secretion abilities of partially grown oocytes.
In summary, we demonstrated from the current study that
SCF can activate oocyte Kit downstream PI3 kinase/Akt in
vitro and supposedly suppress FKHRL1 in oocytes of
primordial, primary and pre-antral follicles. By this study,not only the signaling pathways downstream of oocyte
surface Kit were investigated, but also a connection between
granulosa cell produced SCF and oocyte-derived PI3 kinase
that may control follicular activation and development was
proposed. However, downstream effectors of Akt and
FKHRL1 in mammalian oocytes are not yet identified.
Direct evidence for functional roles of the oocyte PI3 kinase
pathway needs to be obtained by in vivo approaches using
gene-deficient or transgenic mice. Further researches
addressing these questions are on their way in our
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